Development of Vi conjugate – a new generation of typhoid vaccine

Informa UK Limited - Tập 12 Số 11 - Trang 1273-1286 - 2013
Shousun C. Szu1
1Eunice Kennedy Shriver National Institute of Child Health & Human Development, National Institutes of Health, 9402 Wildoak Drive, Bethesda, Maryland, MD 20814, USA.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Wright AE, 1896, Lancet, 2, 807, 10.1016/S0140-6736(01)75566-3

Marsden RW, 1900, Br. Med. J, 1, 1017, 10.1136/bmj.1.2052.1017

Green PH, 1844, Prov. Med. Surg. J, 7, 468

Crump JA, 2004, Bull. Wld. Hlth. Org, 82, 346

Ochai RL, 2008, Bull. Wld. Hlth. Org, 86, 260, 10.2471/BLT.06.039818

Parry CM, 2007, Antimicrob. Agents Chemother, 51, 819, 10.1128/AAC.00447-06

Zaki SA, 2011, J. Infect. Dev. Ctries, 5, 324, 10.3855/jidc.1405

Mermin JH, 1999, J. Infect. Dis, 179, 1416, 10.1086/314766

Mason WP, 1909, Science, 30, 117, 10.1126/science.30.760.117-a

Senthilkumar B, 2005, Indian J. Med. Microbiol, 23, 92, 10.4103/0255-0857.16046

Dutta U, 2000, Am. J. Gastroenterol, 97, 784, 10.1111/j.1572-0241.2000.01860.x

Engleberg NC, 1983, J. Clin. Microbiol, 18, 1320, 10.1128/JCM.18.6.1320-1322.1983

Khan MI, 2010, Expert Rev. Vaccines, 9, 485, 10.1586/erv.10.43

McGregor AC, 2013, Curr. Opin. Infect. Dis, 26, 254, 10.1097/QCO.0b013e32835fb829

Wahdan MH, 1980, Bull. World Health Organ, 58, 469

Acharya IL, 1987, N. Engl. J. Med, 317, 1101, 10.1056/NEJM198710293171801

Klugman KP, 1987, Lancet, 2, 165

Yang HH, 2001, Bull. World Health Org, 79, 625

Simanjuntak CH, 1991, Lancet, 338, 1055, 10.1016/0140-6736(91)91910-M

Yang HH, 1999, J. Infect. Dis, 183, 1775, 10.1086/320729

Khan MI, 2012, Vaccine, 30, 5389, 10.1016/j.vaccine.2012.06.015

Mtove G, 2010, PLoS ONE, 2, 1

House D, 2001, J. Clin. Microbiol, 39, 1002, 10.1128/JCM.39.3.1002-1007.2001

The diagnosis, treatment and prevention of typhoid fever, 2003, World Health Org. Vaccine Biol, 03, 1

Keddy KH, 2011, Bull. World Health Org, 89, 640, 10.2471/BLT.11.087627

Brooks WA, 2005, Emerg. Infect. Dis, 11, 326, 10.3201/eid1102.040422

Sinha A., 1999, Lancet, 354, 734, 10.1016/S0140-6736(98)09001-1

Owais A, 2010, Pediatr. Infect. Dis. J, 29, 1035, 10.1097/INF.0b013e3181e39f8b

Saha SK, 2001, Pediatr. Infect. Dis. J, 20, 521, 10.1097/00006454-200105000-00010

Robbins JD, 1984, J. Infect. Dis, 150, 436, 10.1093/infdis/150.3.436

Robbins JB, 1988, Monogr. Allergy, 24, 315

10.1128/IAI.68.5.2692-2697.2000

Choo S, 2000, J. Infect. Dis, 182, 1260, 10.1086/315834

10.1016/j.vaccine.2012.09.019

10.1016/S0092-1157(82)80010-3

Adam HJ, 2010, Vaccine, 28, 4073, 10.1016/j.vaccine.2010.03.075

Rashid H, 2012, Curr. Opin. Infect. Dis, 25, 243, 10.1097/QCO.0b013e328352f727

Keitel WA, 1994, Vaccine, 12, 195, 10.1016/0264-410X(94)90194-5

Robbins JB, 1996, JAMA, 276, 1181, 10.1001/jama.276.14.1181

Claesson BA, 1996, Pediatr. Infect. Dis. J, 15, 170, 10.1097/00006454-199602000-00016

Elemraid MA, 2012, Epidemiol. Infect, 19, 1

Vesikari T, 2012, Hum. Vaccine Immunother, 8, XXX

Robbins JB, 1989, Curr. Top. Microbiol. Immunol, 146, 169

Lanh MN, 2003, N. Engl. J. Med, 349, 1390, 10.1056/NEJM200310023491423

Stone AL, 1988, J. Clin. Microbiol, 26, 719, 10.1128/JCM.26.4.719-725.1988

Szu SC, 1991, Infect. Immun, 59, 4555, 10.1128/IAI.59.12.4555-4561.1991

Szu SC, 1989, Infect. Immun, 57, 3823, 10.1128/IAI.57.12.3823-3827.1989

10.1084/jem.166.5.1510

Szu SC, 1994, Infect. Immun, 62, 4440, 10.1128/IAI.62.10.4440-4444.1994

Kossaczka Z, 1997, Infect. Immun, 65, 2088, 10.1128/IAI.65.6.2088-2093.1997

An SJ, 2012, Vaccine, 30, 1023, 10.1016/j.vaccine.2011.12.046

Lu YJ, 2012, Vaccine, 30, 3405, 10.1016/j.vaccine.2012.03.039

Micoli F, 2012, Vaccine, 30, 853, 10.1016/j.vaccine.2011.11.108

Rijpkema S, 2004, Biologicals, 32, 11, 10.1016/j.biologicals.2003.09.002

Robbins JB, 1988, Dev. Biol. Stand, 95, 161

2006, Worlld Health Org. Tech. Rep. Ser, 962, 117

Hendriksen CFM, 2008, Expert Rev. Vaccines, 8, 313, 10.1586/14760584.8.3.313

Kossaczka Z, 1999, Infect. Immun, 67, 5806, 10.1128/IAI.67.11.5806-5810.1999

Lin F. Y. C., 2001, N. Engl. J. Med, 344, 1263, 10.1056/NEJM200104263441701

Thiem VD, 2011, Clin. Vaccine Immunol, 18, 730, 10.1128/CVI.00532-10

Canh DG, 2004, Infect. Immun, 72, 6586, 10.1128/IAI.72.11.6586-6588.2004

Lin FY, 2000, Am. J. Trop. Med. Hyg, 62, 644, 10.4269/ajtmh.2000.62.644

Fernández J, 2000, Am. J. Trop. Med. Hyg, 62, 485, 10.4269/ajtmh.2000.62.485

Ahman H, 1999, Vaccine, 17, 2726, 10.1016/S0264-410X(99)00048-1

van Damme P, 2011, PLoS ONE, 6, e25398, 10.1371/journal.pone.0025398

Glezen WP, 2003, Vaccine, 21, 3389, 10.1016/S0264-410X(03)00339-6

Healy CM, 2004, J. Infect. Dis, 190, 335, 10.1086/421033

Klugman KP, 1996, Vaccine, 14, 435, 10.1016/0264-410X(95)00186-5

Fattom A, 1990, Infect. Immun, 58, 2309, 10.1128/IAI.58.7.2309-2312.1990

Konadu EY, 1998, J. Infect. Dis, 177, 383, 10.1086/514203

Passwell JH, 2003, Pediatr. Infect. Dis. J, 22, 701, 10.1097/01.inf.0000078156.03697.a5

Fattom A, 2004, Vaccine, 23, 656, 10.1016/j.vaccine.2004.06.043

Coalition against typhoid, 2013, The 8th International Conference on Typhoid Fever and Other Invasive Salmonelloses

Rondini S, 2012, J. Infect. Dev. Ctries, 6, 763, 10.3855/jidc.2495

Global routine vaccination coverage, 2010, 2011, Morb. Mortal. Wkly. Rep, 60, 1520

Staats HF, 2010, Clin. Vacc. Immunol, 17, 412, 10.1128/CVI.00354-09

Wahid R, 2011, Clin. Immunol, 138, 187, 10.1016/j.clim.2010.11.006

Sur D, 2009, N. Engl. J. Med, 361, 335, 10.1056/NEJMoa0807521

Broome CV, 1991, NIPH Ann, 14, 219

Robbins JB, 1973, Pediatr. Res, 7, 103, 10.1203/00006450-197303000-00001

Quataert SA, 1995, Clin. Diag. Lab. Immun, 2, 590, 10.1128/CDLI.2.5.590-597.1995

Holder PK, 1995, Clin. Diag. Lab. Immun, 2, 132, 10.1128/CDLI.2.2.132-137.1995

Szu SC, 2013, Vaccine, 31, 1970, 10.1016/j.vaccine.2013.02.006

Laboratory of Microbiology, In-Vivo Testing and Standards, Division of Biological Standards and Quality Control, Office of Compliance and Biologics Quality, Center for Biologics Evaluation & Research (CBER), US Food & Drug Administration.

Ellis H, 2011, Br. J. Hosp. Med. (Lond.), 72, 169, 10.12968/hmed.2011.72.3.169

Nelson CB, 2011, Vaccine, 29, 6443, 10.1016/j.vaccine.2011.06.006

10.1586/14760584.6.3.293

10.4161/hv.3.2.3715

Robbins JB, 1995, J. Infect. Dis, 171, 1387, 10.1093/infdis/171.6.1387

Robbins JB, 1996, Adv. Exp. Med. Biol, 397, 169, 10.1007/978-1-4899-1382-1_22

Jones C, 2013, Vaccine, 31, 4466, 10.1016/j.vaccine.2013.07.070

Lauria DT, 2009, Vaccine, 27, 1609, 10.1016/j.vaccine.2008.12.032

Feasey NA, 2012, Lancet, 379, 2489, 10.1016/S0140-6736(11)61752-2

Crump JA, 2010, Clin. Infect. Dis, 50, 241, 10.1086/649541

Konadu EY, 2000, Infect. Immun, 68, 1529, 10.1128/IAI.68.3.1529-1534.2000

Watson DC, 1992, Infect. Immun, 60, 4679, 10.1128/IAI.60.11.4679-4686.1992

Simon R, 2011, Enteritidis. Infect. Immun, 79, 4240, 10.1128/IAI.05484-11

Micoli F, 2013, Anal. Biochem, 434, 136, 10.1016/j.ab.2012.10.038